Author:
Bir Yücel Kadriye,Sutcuoglu Osman,Yazıcı Ozan,Ozet Ahmet,Ozdemir Nuriye
Subject
Gastroenterology,Hepatology
Reference7 articles.
1. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial;Reynolds;Lancet Gastroenterol Hepatol,2023
2. Measures of follow-up in time-to-event studies: why provide them and what should they be?;Betensky;Clin Trials,2015
3. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial;Eyck;J Clin Oncol,2021
4. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;Lancet,2012
5. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial